Drug Shortage Report for TYLENOL EXTRA STRENGTH
| Report ID | 280698 |
| Drug Identification Number | 00559407 |
| Brand name | TYLENOL EXTRA STRENGTH |
| Common or Proper name | Tylenol |
| Company Name | KENVUE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | Regular |
| Anatomical Therapeutical Chemical (ATC) code | N02BE |
| Anatomical Therapeutical Chemical (ATC) description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2028-01-01 |
| Actual start date | |
| Estimated end date | 2032-01-01 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-24 |
| Company comments | English |
| Health Canada comments | English HC |
| Tier 3 Status | No |
| Contact Address | 890 WOODLAWN ROAD WEST GUELPH, ONTARIO CANADA N1K 1A5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-24 | French | Compare |
| v1 | 2026-03-24 | English | Compare |
Showing 1 to 2 of 2